KHAN NAJAT (CEO and President) sold 1.2% of their position (28.30K shares) of RECURSION PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $94.7K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/11/2026ACC: 0001601830-26-000048
DirectorOfficer· CEO and President
Since Feb 2026
-28.30K
Net shares
Net seller
$94.7K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
28.30K disposed
Non-Derivative Transactions1
Class A Common Stock
Direct
Shares
−28.30K
Price / share
$3.35
Trade value
$94.66K
% of position
1.2%
3/9/2026
2.29M→2.26M
Total
Net shares
−28.30K
Net value
-$94.66K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 3/9/2026 | S · Sale | −28.30K | $3.35 | $94.66K | 1.2% | 2.29M | 2.26M |
| Total | −28.30K | -$94.66K | ||||||
Derivative Transactions0
No derivative transactions reported